Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2006-10-17
Original market date: See footnote 1
1996-12-31
Product name:
HYTRIN-7 TABS 1MG-7 TABS 2MG-14 TABS 5MG
DIN:
02187876
Product Monograph/Veterinary Labelling:
Date:
2006-06-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ABBOTT LABORATORIES, LIMITED
8401 Trans-Canada Highway
Saint-Laurent
Quebec
Canada
H4S 1Z1
Class:
Human
Dosage form(s):
Tablet , Kit
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G04CA03 TERAZOSIN
Active ingredient group (AIG) number:See footnote5
0336814001
| Active ingredient(s) | Strength |
|---|---|
| TERAZOSIN (TERAZOSIN HYDROCHLORIDE) | 1 MG |
| TERAZOSIN (TERAZOSIN HYDROCHLORIDE) | 2 MG |
| TERAZOSIN (TERAZOSIN HYDROCHLORIDE) | 5 MG |